CDK1/2/5 inhibition overcomes IFNG-mediated adaptive immune resistance in pancreatic cancer | Gut

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens
Log in via BSG

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Article metrics

Pancreas

Original research

CDK1/2/5 inhibition overcomes IFNG-mediated adaptive immune resistance in pancreatic cancer

Online download statistics by month:

Online download statistics by month: August 2020 to March 2024

	Abstract	Full	Pdf
Aug 2020	787	85	41
Sep 2020	1560	99	49
Oct 2020	289	56	30
Nov 2020	333	57	28
Dec 2020	139	29	17
Jan 2021	186	34	8
Feb 2021	212	17	11
Mar 2021	245	44	29
Apr 2021	714	98	53
May 2021	212	64	35
Jun 2021	34	29	11
Jul 2021	65	50	16
Aug 2021	52	42	25
Sep 2021	60	46	23
Oct 2021	321	38	19
Nov 2021	691	37	15
Dec 2021	997	58	20
Jan 2022	414	53	20
Feb 2022	394	31	10
Mar 2022	604	70	23
Apr 2022	487	52	23
May 2022	457	44	10
Jun 2022	314	44	23
Jul 2022	315	42	17
Aug 2022	487	45	16
Sep 2022	486	32	6
Oct 2022	624	48	9
Nov 2022	642	40	13
Dec 2022	456	26	8
Jan 2023	447	27	8
Feb 2023	552	28	7
Mar 2023	517	30	8
Apr 2023	502	31	9
May 2023	202	16	5
Jun 2023	172	10	3
Jul 2023	262	17	3
Aug 2023	288	21	6
Sep 2023	283	25	4
Oct 2023	400	24	11
Nov 2023	720	19	8
Dec 2023	235	16	16
Jan 2024	386	25	19
Feb 2024	175	8	10
Mar 2024	290	26	24
Total	18008	1733	749